81 – 90 of 127
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin.
(
- Contribution to journal › Article
-
Mark
Harnessing immune alterations in neurodegenerative diseases.
(
- Contribution to journal › Article
-
Mark
Malignt neuroleptikasyndrom--sällsynt diagnos med hög dödlighet.
(
- Contribution to journal › Scientific review
-
Mark
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
(
- Contribution to journal › Article
-
Mark
Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model
(
- Contribution to journal › Article
- 2008
-
Mark
Cocaine and amphetamine regulated transcript (CART) in suicide attempters.
(
- Contribution to journal › Article
-
Mark
Hippocampal cytogenesis is increased in FSL strain, a genetic rat model of depression. Escitalopram reduces increased cell number
2008) XXVI CINP Congress In International Journal of Neuropsychopharmacology 11(Supplement S1). p.124-125(
- Contribution to journal › Published meeting abstract
-
Mark
Increased metabolism in the R6/2 mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Transthyretin in cerebrospinal fluid from suicide attempters.
(
- Contribution to journal › Article
-
Mark
Role of neuroticism and neurochemical changes in suicidal behaviour
2008) XXVI CINP Congress In International Journal of Neuropsychopharmacology 11(Supplement S1). p.132-132(
- Contribution to journal › Published meeting abstract